Stock Ticker

  • Loading stock data...

AVEO Pharmaceuticals, Inc.’s (NASDAQ:AVEO) TIVO-3 Trial Results Inconclusive And Uninterpretable

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) issued a regulatory update after a meeting with the U.S. FDA to discuss data from the August 2019 OS analysis of the TIVO-3 study. The company also issued an update on its proposal to advance with a New Drug Application for tivozanib. The TIVO-3 study was planned to resolve the FDA’s […]

Sign Up To Get Our Latest Stocks Alerts